{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T01:23:11Z","timestamp":1793150591630,"version":"4.5.0"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T00:00:00Z","timestamp":1773446400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T00:00:00Z","timestamp":1773446400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004252","name":"Qatar University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004252","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Probiotics &amp; Antimicro. Prot."],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1007\/s12602-026-10956-5","type":"journal-article","created":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T02:26:58Z","timestamp":1773455218000},"page":"7605-7630","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Bridging Generative AI and Diffusion Models With Molecular Simulation to Design Anti-Quorum-Sensing De novo Peptides Targeting LasR of Pseudomonas aeruginosa"],"prefix":"10.1007","volume":"18","author":[{"given":"Abbas","family":"Khan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mona A.","family":"Sawali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anwar","family":"Mohammad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fakhrul","family":"Hasssan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fahad M.","family":"Alshabrmi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eid A.","family":"Alatawi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergio","family":"Crovella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong-Qing","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdelali","family":"Agouni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,14]]},"reference":[{"key":"10956_CR1","doi-asserted-by":"crossref","unstructured":"Hu M, Chua SL (2025) Antibiotic-Resistant Pseudomonas aeruginosa: Current Challenges and Emerging Alternative Therapies, Microorganisms, 13","DOI":"10.3390\/microorganisms13040913"},{"key":"10956_CR2","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1097\/JS9.0000000000000184","volume":"109","author":"M Saravanan","year":"2023","unstructured":"Saravanan M, Belete MA, Arockiaraj J (2023) Carbapenem-resistant Pseudomonas aeruginosa in intensive care units increase mortality as an emerging global threat. Int J Surg 109:1034\u20131036","journal-title":"Int J Surg"},{"key":"10956_CR3","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1165\/rcmb.2017-0321TR","volume":"58","author":"NM Maurice","year":"2018","unstructured":"Maurice NM, Bedi B, Sadikot RT (2018) Pseudomonas aeruginosa biofilms: host response and clinical implications in lung infections. Am J Respir Cell Mol Biol 58:428\u2013439","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10956_CR4","doi-asserted-by":"publisher","first-page":"312","DOI":"10.3390\/biologics1030019","volume":"1","author":"A Vetrivel","year":"2021","unstructured":"Vetrivel A, Ramasamy M, Vetrivel P, Natchimuthu S, Arunachalam S, Kim G-S, Murugesan R (2021) Pseudomonas aeruginosa biofilm formation and its control. Biologics 1:312\u2013336","journal-title":"Biologics"},{"key":"10956_CR5","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1093\/jac\/49.2.309","volume":"49","author":"P-C Shih","year":"2002","unstructured":"Shih P-C, Huang C-T (2002) Effects of quorum-sensing deficiency on Pseudomonas aeruginosa biofilm formation and antibiotic resistance. J Antimicrob Chemother 49:309\u2013314","journal-title":"J Antimicrob Chemother"},{"key":"10956_CR6","doi-asserted-by":"crossref","unstructured":"McCready AR, Paczkowski JE, Henke BR, Bassler BL (2019) Structural determinants driving homoserine lactone ligand selection in the <\u2009i>Pseudomonas aeruginosa LasR quorum-sensing receptor, Proceedings of the National Academy of Sciences, 116 245\u2013254","DOI":"10.1073\/pnas.1817239116"},{"key":"10956_CR7","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1038\/ismej.2011.13","volume":"5","author":"CN Wilder","year":"2011","unstructured":"Wilder CN, Diggle SP, Schuster M (2011) Cooperation and cheating in Pseudomonas aeruginosa: the roles of the las, Rhl and Pqs quorum-sensing systems. Isme J 5:1332\u20131343","journal-title":"Isme J"},{"key":"10956_CR8","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.jbiotec.2014.09.003","volume":"191","author":"PK Taylor","year":"2014","unstructured":"Taylor PK, Yeung AT, Hancock RE (2014) Antibiotic resistance in Pseudomonas aeruginosa biofilms: towards the development of novel anti-biofilm therapies. J Biotechnol 191:121\u2013130","journal-title":"J Biotechnol"},{"key":"10956_CR9","doi-asserted-by":"publisher","first-page":"1676","DOI":"10.1128\/AAC.02533-15","volume":"60","author":"A Furiga","year":"2016","unstructured":"Furiga A, Lajoie B, El Hage S, Baziard G, Roques C (2016) Impairment of Pseudomonas aeruginosa biofilm resistance to antibiotics by combining the drugs with a new quorum-sensing inhibitor. Antimicrob Agents Chemother 60:1676\u20131686","journal-title":"Antimicrob Agents Chemother"},{"key":"10956_CR10","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1007\/s10123-023-00338-0","volume":"26","author":"A Vetrivel","year":"2023","unstructured":"Vetrivel A, Vetrivel P, Dhandapani K, Natchimuthu S, Ramasamy M, Madheswaran S, Murugesan R (2023) Inhibition of biofilm formation, quorum sensing and virulence factor production in Pseudomonas aeruginosa PAO1 by selected LasR inhibitors. Int Microbiol 26:851\u2013868","journal-title":"Int Microbiol"},{"key":"10956_CR11","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.bjid.2018.03.003","volume":"22","author":"J Lima","year":"2018","unstructured":"Lima J, Alves LR, Jacom\u00e9 P, Bezerra Neto JP, Maciel MAV, Morais MMC (2018) Biofilm production by clinical isolates of Pseudomonas aeruginosa and structural changes in LasR protein of isolates Non biofilm-producing. Brazilian J Infect Diseases: Official Publication Brazilian Soc Infect Dis 22:129\u2013136","journal-title":"Brazilian J Infect Diseases: Official Publication Brazilian Soc Infect Dis"},{"key":"10956_CR12","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1016\/j.molcel.2020.12.011","volume":"81","author":"M Shah","year":"2021","unstructured":"Shah M, Taylor VL, Bona D, Tsao Y, Stanley SY, Pimentel-Elardo SM, McCallum M, Bondy-Denomy J, Howell PL, Nodwell JR, Davidson AR, Moraes TF, Maxwell KL (2021) A phage-encoded anti-activator inhibits quorum sensing in <\u2009em>Pseudomonas aeruginosa. Mol Cell 81:571\u2013583e576","journal-title":"Mol Cell"},{"key":"10956_CR13","doi-asserted-by":"publisher","first-page":"140119","DOI":"10.1016\/j.ijbiomac.2025.140119","volume":"300","author":"HA Alhadrami","year":"2025","unstructured":"Alhadrami HA, Sayed AM, Hassan HM, Rateb ME, Taha MN (2025) Optimized peptide inhibitor Aqs1C targets LasR to disrupt quorum sensing and biofilm formation in Pseudomonas aeruginosa: insights from MD simulations and in vitro studies. Int J Biol Macromol 300:140119","journal-title":"Int J Biol Macromol"},{"key":"10956_CR14","doi-asserted-by":"publisher","first-page":"104300","DOI":"10.1016\/j.drudis.2025.104300","volume":"30","author":"S Zhai","year":"2025","unstructured":"Zhai S, Liu T, Lin S, Li D, Liu H, Yao X, Hou T (2025) Artificial intelligence in peptide-based drug design. Drug Discovery Today 30:104300","journal-title":"Drug Discovery Today"},{"issue":"22","key":"10956_CR15","doi-asserted-by":"publisher","first-page":"e40265","DOI":"10.1016\/j.heliyon.2024.e40265","volume":"10","author":"P HashemiS, Vosough","year":"2024","unstructured":"HashemiS, Vosough P, Taghizadeh S, Savardashtaki A (2024) Therapeutic peptide development revolutionized: Harnessing the power of artificial intelligence for drug discovery. Heliyon 10(22):e40265. https:\/\/doi.org\/10.1016\/j.heliyon.2024.e40265","journal-title":"Heliyon"},{"key":"10956_CR16","doi-asserted-by":"publisher","unstructured":"Chen X, Chen Z, Xu D, Lyu Y, Li Y, Li S, Wang J, Wang Z (2021) De Novo design of G Protein-Coupled receptor 40 peptide agonists for type 2 diabetes mellitus based on artificial intelligence and Site-Directed Mutagenesis. Front Bioeng Biotechnol 9:694100. https:\/\/doi.org\/10.3389\/fbioe.2021.694100","DOI":"10.3389\/fbioe.2021.694100"},{"key":"10956_CR17","doi-asserted-by":"crossref","unstructured":"Cho S, Zhu R, Kuncewicz K, Duan H, Gabr M (2025) AI-guided design of cyclic peptide binders targeting TREM2 using cycleRFdiffusion and experimental validation. bioRxiv 2025.2009.2018.676322","DOI":"10.1101\/2025.09.18.676322"},{"key":"10956_CR18","doi-asserted-by":"publisher","first-page":"2500043","DOI":"10.1002\/adma.202500043","volume":"37","author":"Z Jiang","year":"2025","unstructured":"Jiang Z, Feng J, Wang F, Wang J, Wang N, Zhang M, Hsieh C-Y, Hou T, Cui W, Ma L (2025) AI-Guided design of antimicrobial peptide hydrogels for precise treatment of Drug-resistant bacterial infections. Adv Mater 37:2500043","journal-title":"Adv Mater"},{"key":"10956_CR19","doi-asserted-by":"publisher","first-page":"9566","DOI":"10.1021\/acs.jcim.5c00892","volume":"65","author":"C Tian","year":"2025","unstructured":"Tian C, Hao Y, Fu H, Shao X, Cai W (2025) From AI-Driven sequence generation to molecular simulation: A comprehensive framework for antimicrobial peptide discovery. J Chem Inf Model 65:9566\u20139575","journal-title":"J Chem Inf Model"},{"key":"10956_CR20","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1038\/s41586-023-06953-1","volume":"626","author":"S V\u00e1zquez Torres","year":"2024","unstructured":"V\u00e1zquez Torres S, Leung PJ, Venkatesh P, Lutz ID, Hink F, Huynh H-H, Becker J, Yeh AH-W, Juergens D, Bennett NR (2024) De Novo design of high-affinity binders of bioactive helical peptides. Nature 626:435\u2013442","journal-title":"Nature"},{"key":"10956_CR21","doi-asserted-by":"publisher","first-page":"1631","DOI":"10.1016\/j.str.2025.08.007","volume":"33","author":"DR Fox","year":"2025","unstructured":"Fox DR, Taveneau C, Clement J, Grinter R, Knott GJ (2025) Code to complex: AI-driven de Novo binder design. Structure 33:1631\u20131642","journal-title":"Structure"},{"key":"10956_CR22","doi-asserted-by":"crossref","unstructured":"Shah M, Woo HG, Therapeutics P (2025) AI-driven design and structural bioengineering. KOBRA Reports 1","DOI":"10.64066\/kobrareports.25.0025"},{"key":"10956_CR23","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1016\/j.str.2020.08.005","volume":"28","author":"OV Sobolev","year":"2020","unstructured":"Sobolev OV, Afonine PV, Moriarty NW, Hekkelman ML, Joosten RP, Perrakis A, Adams PD (2020) A global ramachandran score identifies protein structures with unlikely stereochemistry. Structure 28:1249\u20131258.e1242","journal-title":"Structure"},{"key":"10956_CR24","doi-asserted-by":"publisher","first-page":"e4792","DOI":"10.1002\/pro.4792","volume":"32","author":"EC Meng","year":"2023","unstructured":"Meng EC, Goddard TD, Pettersen EF, Couch GS, Pearson ZJ, Morris JH, Ferrin TE (2023) UCSF chimerax: tools for structure Building and analysis. Protein Sci 32:e4792","journal-title":"Protein Sci"},{"key":"10956_CR25","doi-asserted-by":"crossref","unstructured":"Bell J, Cao Y, Gunn J, Day T, Gallicchio E, Zhou Z, Levy R, Farid R (2012) PrimeX and the Schr\u00f6dinger computational chemistry suite of programs","DOI":"10.1107\/97809553602060000864"},{"key":"10956_CR26","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1002\/pro.3289","volume":"27","author":"RA Laskowski","year":"2018","unstructured":"Laskowski R.A., Jab\u0142o\u0144ska J., Pravda L., Va\u0159ekov\u00e1 R.S., Thornton J.M. (2018) PDBsum: structural summaries of PDB entries. Protein Sci 27:129\u2013134","journal-title":"Protein Sci"},{"key":"10956_CR27","first-page":"e1298","volume":"7","author":"S Yuan","year":"2017","unstructured":"Yuan S, Chan HS, Hu Z (2017) Using PyMOL as a platform for computational drug design. Wiley Interdisciplinary Reviews: Comput Mol Sci 7:e1298","journal-title":"Wiley Interdisciplinary Reviews: Comput Mol Sci"},{"key":"10956_CR28","doi-asserted-by":"crossref","unstructured":"Rustamov KR, Baev AY (2025) Fold-conditioned de novo binder design via alphaFold2-multimer hallucination, bioRxiv, 2025.2007.2002.662497","DOI":"10.1101\/2025.07.02.662497"},{"key":"10956_CR29","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1126\/science.add2187","volume":"378","author":"J Dauparas","year":"2022","unstructured":"Dauparas J, Anishchenko I, Bennett N, Bai H, Ragotte RJ, Milles LF, Wicky BI, Courbet A, de Haas RJ, Bethel N (2022) Robust deep learning\u2013based protein sequence design using ProteinMPNN. Science 378:49\u201356","journal-title":"Science"},{"key":"10956_CR30","doi-asserted-by":"publisher","first-page":"9135","DOI":"10.1021\/acs.jcim.4c00975","volume":"64","author":"F Wang","year":"2024","unstructured":"Wang F, Wang Y, Feng L, Zhang C, Lai L (2024) Target-specific de Novo peptide binder design with diffpepbuilder. J Chem Inf Model 64:9135\u20139149","journal-title":"J Chem Inf Model"},{"key":"10956_CR31","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1038\/s41586-023-06415-8","volume":"620","author":"JL Watson","year":"2023","unstructured":"Watson JL, Juergens D, Bennett NR, Trippe BL, Yim J, Eisenach HE, Ahern W, Borst AJ, Ragotte RJ, Milles LF (2023) De Novo design of protein structure and function with rfdiffusion. Nature 620:1089\u20131100","journal-title":"Nature"},{"key":"10956_CR32","unstructured":"Bryant P, Elofsson A (2022) EvoBind: in silico directed evolution of peptide binders with AlphaFold, bioRxiv, 2022.2007. 2023.501214"},{"key":"10956_CR33","unstructured":"MilliporeSigma (2025) Solubility guidelines for peptides. Sigma-Aldrich"},{"issue":"9","key":"10956_CR34","doi-asserted-by":"publisher","first-page":"5002","DOI":"10.3390\/ijms22095002","volume":"22","author":"M Ptak-Kaczor","year":"2021","unstructured":"Ptak-Kaczor M, Banach M, Stapor K, Fabian P, Konieczny L, Roterman I (2021) Solubility and aggregation of selected proteins interpreted on the basis of hydrophobicity distribution. Int J Mol Sci 22(9):5002. https:\/\/doi.org\/10.3390\/ijms22095002","journal-title":"Int J Mol Sci"},{"key":"10956_CR35","doi-asserted-by":"publisher","first-page":"20170030","DOI":"10.1098\/rsfs.2017.0030","volume":"7","author":"KL Zapadka","year":"2017","unstructured":"Zapadka KL, Becher FJ, Gomes Dos Santos AL, Jackson SE (2017) Factors affecting the physical stability (aggregation) of peptide therapeutics. Interface Focus 7:20170030","journal-title":"Interface Focus"},{"key":"10956_CR36","unstructured":"Nori D, Parsan A, Uhler C, Jin W (2025) BindEnergyCraft: Casting protein structure predictors as energy-based models for binder design, arXiv preprint arXiv:2505.21241"},{"key":"10956_CR37","doi-asserted-by":"publisher","first-page":"W170","DOI":"10.1093\/nar\/gkae382","volume":"52","author":"O B\u00e1rcenas","year":"2024","unstructured":"B\u00e1rcenas O, Kuriata A, Zalewski M, Iglesias V, Pintado-Grima C, Firlik G, Burdukiewicz M, Kmiecik S, Ventura S (2024) Aggrescan4D: structure-informed analysis of pH-dependent protein aggregation. Nucleic Acids Res 52:W170\u2013W175","journal-title":"Nucleic Acids Res"},{"key":"10956_CR38","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1093\/bioinformatics\/btq007","volume":"26","author":"S Chaudhury","year":"2010","unstructured":"Chaudhury S, Lyskov S, Gray JJ (2010) PyRosetta: a script-based interface for implementing molecular modeling algorithms using Rosetta. Bioinformatics 26:689\u2013691","journal-title":"Bioinformatics"},{"key":"10956_CR39","doi-asserted-by":"crossref","unstructured":"Jeliazkov JR, del Alamo D, Karpiak JD (2023) ESMFold hallucinates native-like protein sequences, bioRxiv, 2023.2005. 2023.541774","DOI":"10.1101\/2023.05.23.541774"},{"key":"10956_CR40","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1038\/s41586-024-07487-w","volume":"630","author":"J Abramson","year":"2024","unstructured":"Abramson J, Adler J, Dunger J, Evans R, Green T, Pritzel A, Ronneberger O, Willmore L, Ballard AJ, Bambrick J (2024) Accurate structure prediction of biomolecular interactions with alphafold 3. Nature 630:493\u2013500","journal-title":"Nature"},{"key":"10956_CR41","first-page":"198","volume":"3","author":"R Salomon-Ferrer","year":"2013","unstructured":"Salomon-Ferrer R, Case DA, Walker RC (2013) An overview of the amber biomolecular simulation package. Wiley Interdisciplinary Reviews: Comput Mol Sci 3:198\u2013210","journal-title":"Wiley Interdisciplinary Reviews: Comput Mol Sci"},{"key":"10956_CR42","doi-asserted-by":"crossref","unstructured":"Zhou F, Guo S, Peng X, Zhang S, Men C, Duan X, Zhu G, Zheng L, Liu H, Wang S (2025) Benchmarking alphaFold3-like methods for protein-peptide complex prediction, bioRxiv, 2025.2003.2009.642277","DOI":"10.1101\/2025.03.09.642277"},{"key":"10956_CR43","doi-asserted-by":"publisher","first-page":"e70338","DOI":"10.1002\/pro.70338","volume":"34","author":"Y Wang","year":"2025","unstructured":"Wang Y, Wang F, Feng L, Zhang C, Lai L (2025) DiffPepDock: efficient protein\u2013peptide Docking and binder screening via SE(3)-equivariant diffusion. Protein Sci 34:e70338","journal-title":"Protein Sci"},{"key":"10956_CR44","doi-asserted-by":"crossref","unstructured":"Passaro S, Corso G, Wohlwend J, Reveiz M, Thaler S, Somnath VR, Getz N, Portnoi T, Roy J (2025) H. Stark, Boltz-2: Towards accurate and efficient binding affinity prediction, BioRxiv","DOI":"10.1101\/2025.06.14.659707"},{"key":"10956_CR45","doi-asserted-by":"publisher","first-page":"3676","DOI":"10.1093\/bioinformatics\/btw514","volume":"32","author":"LC Xue","year":"2016","unstructured":"Xue LC, Rodrigues JP, Kastritis PL, Bonvin AM, Vangone A (2016) PRODIGY: a web server for predicting the binding affinity of protein\u2013protein complexes. Bioinformatics 32:3676\u20133678","journal-title":"Bioinformatics"},{"key":"10956_CR46","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1021\/acs.jctc.9b00591","volume":"16","author":"C Tian","year":"2020","unstructured":"Tian C, Kasavajhala K, Belfon KAA, Raguette L, Huang H, Migues AN, Bickel J, Wang Y, Pincay J, Wu Q (2020) Simmerling, ff19SB: Amino-Acid-Specific protein backbone parameters trained against quantum mechanics energy surfaces in solution. J Chem Theory Comput 16:528\u2013552","journal-title":"J Chem Theory Comput"},{"key":"10956_CR47","unstructured":"Scm (2025) Molecular dynamics \u2014 AMS 2025.1 documentation"},{"key":"10956_CR48","unstructured":"AmberHub (2025) Introduction to principal component analysis"},{"key":"10956_CR49","doi-asserted-by":"publisher","first-page":"10256","DOI":"10.1021\/acs.jpcb.5c04050","volume":"129","author":"J Chen","year":"2025","unstructured":"Chen J, Wang J, Wang W, Yang W, Zhao L, Su J (2025) Conformational transition and recognition mechanism of eukaryotic riboswitches powered by thiamine pyrophosphate analogues: an Elucidation through multiple short molecular dynamics simulations and Markov model. J Phys Chem B 129:10256\u201310271","journal-title":"J Phys Chem B"},{"key":"10956_CR50","doi-asserted-by":"publisher","first-page":"6880","DOI":"10.1021\/acs.jcim.4c01174","volume":"64","author":"J Chen","year":"2024","unstructured":"Chen J, Wang J, Yang W, Zhao L, Hu G (2024) Conformations of KRAS4B affected by its partner binding and G12C mutation: insights from GaMD Trajectory-Image Transformation-Based deep learning. J Chem Inf Model 64:6880\u20136898","journal-title":"J Chem Inf Model"},{"key":"10956_CR51","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1517\/17460441.2015.1032936","volume":"10","author":"S Genheden","year":"2015","unstructured":"Genheden S, Ryde U (2015) The MM\/PBSA and MM\/GBSA methods to estimate ligand-binding affinities. Expert Opin Drug Discov 10:449\u2013461","journal-title":"Expert Opin Drug Discov"},{"key":"10956_CR52","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1016\/j.ijbiomac.2022.01.059","volume":"200","author":"A Khan","year":"2022","unstructured":"Khan A, Waris H, Rafique M, Suleman M, Mohammad A, Ali SS, Khan T, Waheed Y, Liao C, Wei D-Q (2022) The Omicron (B.1.1.529) variant of SARS-CoV-2 binds to the hACE2 receptor more strongly and escapes the antibody response: insights from structural and simulation data. Int J Biol Macromol 200:438\u2013448","journal-title":"Int J Biol Macromol"},{"key":"10956_CR53","doi-asserted-by":"publisher","first-page":"7045","DOI":"10.1002\/jcp.30367","volume":"236","author":"A Khan","year":"2021","unstructured":"Khan A, Zia T, Suleman M, Khan T, Ali SS, Abbasi AA, Mohammad A, Wei D-Q (2021) Higher infectivity of the SARS-CoV-2 new variants is associated with K417N\/T, E484K, and N501Y mutants: an insight from structural data. J Cell Physiol 236:7045\u20137057","journal-title":"J Cell Physiol"},{"issue":"3","key":"10956_CR54","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1089\/adt.2011.0406","volume":"10","author":"JP Landry","year":"2012","unstructured":"Landry JP, Fei Y, Zhu X (2012) Simultaneous measurement of 10,000 protein-ligand affinity constants using microarray-based kinetic constant assays, assay and drug development technologies. Assay Drug Dev Technol 10(3):250\u2013259. https:\/\/doi.org\/10.1089\/adt.2011.0406","journal-title":"Assay Drug Dev Technol"},{"key":"10956_CR55","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1093\/protein\/15.3.185","volume":"15","author":"MG Pikkemaat","year":"2002","unstructured":"Pikkemaat MG, Linssen AB, Berendsen HJ, Janssen DB (2002) Molecular dynamics simulations as a tool for improving protein stability. Protein Eng 15:185\u2013192","journal-title":"Protein Eng"},{"key":"10956_CR56","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1038\/nsb0902-646","volume":"9","author":"M Karplus","year":"2002","unstructured":"Karplus M, McCammon JA (2002) Molecular dynamics simulations of biomolecules. Nat Struct Biol 9:646\u2013652","journal-title":"Nat Struct Biol"},{"key":"10956_CR57","doi-asserted-by":"publisher","unstructured":"Khan A, Heng W, Wang Y, Qiu J, Wei X, Peng S, Saleem S, Khan M, Ali SS, Wei DQ (2021) In Silico and in vitro evaluation of Kaempferol as a potential inhibitor of the SARS-CoV-2 main protease (3CLpro). Phytother Res (6):2841\u20132845. https:\/\/doi.org\/10.1002\/ptr.6998","DOI":"10.1002\/ptr.6998"},{"key":"10956_CR58","doi-asserted-by":"publisher","unstructured":"Wang S, Sun X, Cui W, Yuan S (2022) MM\/PB(GB)SA benchmarks on soluble proteins and membrane proteins. Front Pharmacol 13:1018351. https:\/\/doi.org\/10.3389\/fphar.2022.1018351","DOI":"10.3389\/fphar.2022.1018351"},{"key":"10956_CR59","doi-asserted-by":"publisher","first-page":"25118","DOI":"10.1039\/D3RA04916G","volume":"13","author":"M Bello","year":"2023","unstructured":"Bello M, Bandala C (2023) Evaluating the ability of end-point methods to predict the binding affinity tendency of protein kinase inhibitors. RSC Adv 13:25118\u201325128","journal-title":"RSC Adv"}],"container-title":["Probiotics and Antimicrobial Proteins"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12602-026-10956-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12602-026-10956-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12602-026-10956-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T06:19:46Z","timestamp":1787725186000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12602-026-10956-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,14]]},"references-count":59,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["10956"],"URL":"https:\/\/doi.org\/10.1007\/s12602-026-10956-5","relation":{},"ISSN":["1867-1306","1867-1314"],"issn-type":[{"value":"1867-1306","type":"print"},{"value":"1867-1314","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,14]]},"assertion":[{"value":"30 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethical Consent","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"During the preparation of this manuscript, OpenAI\u2019s ChatGPT (GPT-4-turbo) was used to assist in improving the clarity, organization, and readability of the text. The AI tool was not used to generate scientific hypotheses, interpret results, draw conclusions, or make methodological decisions. All content modified with the assistance of ChatGPT was carefully reviewed, verified, and edited by the authors to ensure scientific accuracy and to preserve the original intent of the work. In addition, ChatGPT was used as a support tool for developing scripts, to automate data-processing workflows, and figure-generation pipelines employed in this study. The underlying data, computational analyses, figures, and interpretations were produced, validated, and finalized by the authors, who take full responsibility for the integrity and accuracy of the reported results.","order":2,"name":"Ethics","label":"Declaration of Generative AI and AI-Assisted Technologies in the Writing Process","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}]}}